Catching Ovarian Cancer Early!
(Ivanhoe Newswire) –Researchers at The University of Texas MD Anderson Cancer Center in Houston are working on a new screening strategy for ovarian cancer that appears to be highly specific for detecting ovarian cancer before it becomes lethal.
Researchers tested the potential of a two-stage ovarian cancer screening strategy that incorporates changes in a blood protein called CA125, which is a known tumor marker. The women were divided into three groups: low, intermediate, and high risk. They found that 5.8 percent of women were of intermediate risk each year, meaning that they should receive a CA125 test in three months.
The specificity of the testing strategy was 99.9 percent, meaning that only 0.1 percent of patients without cancer would be falsely identified as having the disease. Importantly, all of the ovarian cancers were in the early stage. If verified in an ongoing clinical trial, this test could potentially help save the lives of thousands of women each year in the United States alone.
For more information go to: http://www.mdanderson.org/newsroom/news-releases/2013/ca-125-screening-tool-for-ovarian-cancer.html
SOURCE: Cancer, August 2013
Click Here for a free weekly email with Ivanhoe's latest Medical Breakthroughs.